Prevence chronického onemocnění ledvin pravidelným screeningem albuminurie u rizikových skupin pacientů
Chronic kidney disease (CKD) is a severe complication in context
of various civilisation diseases, such as diabetes, hypertension,
and obesity. With increasing treatment cost along the progression
of CKD towards end-stage renal failure (ESRF) and the need for
renal replacement therapies, CKD is not only a driver of premature
mortality and diminished quality of life of affected individuals,
but also puts significant burden on the society and healthcare
expenditures.
The early detection of kidney damage through a frequent screening
of risk patients could help to fight the burden of CKD. Cost-efficient
routine urinalysis data could play a vital role in providing valuable
information for screening, diagnosing, and monitoring of renal
disorders.
